Louisiana State University Health Sciences Center in New Orleans
lsuhsc.eduTotal trials
71
Active
12
Phase 3
6
Total enrollment
7,632
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 12 of 12 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Human papillomavirus 9-valent vaccine, recombinant | — | — | — | — | — | 1 | |
| human papillomavirus vaccine, recombinant | — | — | — | — | — | 1 | |
| Proparacaine Hydrochloride ophthalmic solution, USP 0.5% | — | — | — | — | — | 1 | |
| Balanced salt solution | — | — | — | — | — | 1 | |
| Semaglutide | — | — | — | — | — | 1 | |
| Phentermine-Topiramate combination | — | — | — | — | — | 1 | |
| Phentermine | — | — | — | — | — | 1 | |
| Tirzepatide | — | — | — | — | — | 1 | |
| Topiramate | — | — | — | — | — | 1 | |
| Diethylpropion | — | — | — | — | — | 1 | |
| Naltrexone/Bupropion | — | — | — | — | — | 1 | |
| Liraglutide | — | — | — | — | — | 1 |
Next readouts
- 2022-12-30
- 2025-12
- 2026-01-30
Top conditions
- Dental Caries4
- Pulmonary Hypertension4
- Multiple Sclerosis3
- Systemic Sclerosis2
- Scleroderma2
- HIV Infections2
- Quality of Life2
- Alcohol Use Disorder2
Frequently asked questions about Louisiana State University Health Sciences Center in New Orleans
- How many clinical trials does Louisiana State University Health Sciences Center in New Orleans have on ClinicalTrials.gov?
- Louisiana State University Health Sciences Center in New Orleans is listed as the lead sponsor on 71 clinical trials in ClinicalTrials.gov, 12 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Louisiana State University Health Sciences Center in New Orleans's trials are in Phase 3?
- 6 of Louisiana State University Health Sciences Center in New Orleans's trials are in Phase 3, spread across 12 active drug programs.
- What therapeutic areas does Louisiana State University Health Sciences Center in New Orleans focus on?
- Louisiana State University Health Sciences Center in New Orleans's most-studied conditions on ClinicalTrials.gov are Dental Caries, Pulmonary Hypertension, Multiple Sclerosis, Systemic Sclerosis, Scleroderma.
- When are Louisiana State University Health Sciences Center in New Orleans's next clinical trial readouts?
- Louisiana State University Health Sciences Center in New Orleans has 3 upcoming primary-completion readouts tracked here; the soonest is “Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain?”, expected around 2022-12-30.